Sustaining Home Heart Failure Palliative Care in Rural Appalachia

Description

The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health care, with the help of the faith-based nurses and local volunteer visiting neighbors.

Conditions

Heart Failure NYHA Class III, Heart Failure NYHA Class IV

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health care, with the help of the faith-based nurses and local volunteer visiting neighbors.

Sustaining Home Palliative Care for Patients With Heart Failure (HF) and Their Family Caregivers in Rural Appalachia: A Mixed Methods Randomized Clinical Trial (RCT).

Sustaining Home Heart Failure Palliative Care in Rural Appalachia

Condition
Heart Failure NYHA Class III
Intervention / Treatment

-

Contacts and Locations

Morgantown

West Virginia University Hospital, Morgantown, West Virginia, United States, 26506

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adult patients' age between 50 to 80 years with advanced HF (NYHA III or IV), diagnosed by physician
  • 2. Caregivers' age between 45 to 80 years.
  • 3. Alert and consent to participate
  • 4. Able to read and understand English
  • 1. Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD)
  • 2. Diagnosed with a terminal illness or dementia, such as Alzheimer's disease

Ages Eligible for Study

45 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

West Virginia University,

Ubolrat Piamjariyakul, PRINCIPAL_INVESTIGATOR, West Virginia University School of Nursing

Study Record Dates

2028-05